Jul 9, 2018· Comment from Association for Accessible Medicines· FDA-2018-D-1434-0004
Comments from The Association for Accessible Medicines (AAM) on behalf of our member companies, regarding Docket FDA-2018-D-1434: Waivers, Exceptions, and Exemptions from the Requirements of Section 582 of the Federal Food, Drug, and Cosmetic Act; Draft Guidance for Industry.